why choose us

First received: May 05, 2023

Clinical Trial: Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Study Status: Completed

Recruit Status: RECRUITING

Condition: Esophageal Diseases

Study Type: INTERVENTIONAL


Official Title: Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Brief Summary: Cellspan™ Esophageal Implant-Adult (CEI)The CEI is a combination product consisting of an engineered synthetic scaffold (device constituent) seeded and cultured with the patient's adipose derived mesenchymal stem cells (biologic constituent), intended to stimulate regeneration of a structurally intact, living biologic esophageal conduit, in patients requiring full circumferential esophageal reconstruction up to 6 cm segment in length.This is a single arm, unblinded, multicenter, prospective first-in-human…

Read more